AHA president has asked Congress to intervene and demand HHS take a position on “drug companies’ attempts to hijack the 340B ...

Nonprofit healthcare centers are lobbying for a special exemption from a new Health and Human Services reimbursement review ...

The draft from Sen. Bill Cassidy on reforms to the 340B program requires hospitals to divulge how many people received drugs ...

After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has ...

The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last ...

Lawmaker proposes sweeping 340B reforms to increase transparency, tighten patient eligibility, and cap out-of-pocket costs for low-income patients.

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

Eli Lilly is restricting access to a drug discount program for safety-net hospitals in a move it says is needed to identify ...

The results indicate that the program could play a role in discouraging use of biosimilars in the United States. Hospitals participating in the 340B Drug Pricing Program had lower biosimilar uptake, ...

On May 28, representatives from three states introduced a federal bill to amend the 340B program by recognizing contract pharmacies, restricting pharmacy benefit managers and tightening eligibility ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...

Policies written with the best intentions can be misinterpreted or misused. This is especially true if proper oversight is lacking or if new policy creates unforeseen opportunities. I believe this is ...